Literature DB >> 25611792

Dutch pediatricians' views on the use of neuromuscular blockers for dying neonates: a qualitative study.

K ten Cate1, S van de Vathorst2.   

Abstract

OBJECTIVE: To assess Dutch pediatricians' views on neuromuscular blockers for dying neonates. STUDY
DESIGN: Qualitative study involving in-depth interviews with 10 Dutch pediatricians working with severely ill neonates. Data were analyzed using appropriate qualitative research techniques. RESULT: Participants explained their view on neuromuscular blockers for neonates with a protracted dying process. Major themes were the interpretation of gasping, the role of (the suffering of) the parents, the need for judicial review and legislation's impact on the care participants provide for dying neonates.
CONCLUSION: The interviews show no consensus between pediatricians and provide insights into the points of disagreement. Interviews also suggest friction between the convictions of pediatricians and legislation, which seems to have an undesirable impact on Dutch care for dying neonates and their parents. This study raises important questions for pediatricians worldwide to reflect upon, such as: 'what constitutes 'dying well'?' and 'what role should the parents' perspective play?'.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25611792     DOI: 10.1038/jp.2014.238

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  15 in total

1.  Lingering death after treatment withdrawal in the neonatal intensive care unit.

Authors:  H E McHaffie; A J Lyon; P W Fowlie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

2.  Ethical and legal acceptability of the use of neuromuscular blockers (NMBs) in connection with abstention decisions in Dutch NICUs: interviews with neonatologists.

Authors:  Sofia Moratti
Journal:  J Med Ethics       Date:  2010-10-28       Impact factor: 2.903

3.  The Groningen protocol--euthanasia in severely ill newborns.

Authors:  Eduard Verhagen; Pieter J J Sauer
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

4.  Medication regimes in the context of end-of-life decisions in neonatology: legal considerations with regard to Dutch NICU-practice.

Authors:  Jozef H H M Dorscheidt; Eduard Verhagen; Pieter J J Sauer; Joep H Hubben
Journal:  Med Law       Date:  2013-06

5.  Whom are we comforting? An analysis of comfort medications delivered to dying neonates.

Authors:  Annie Janvier; William Meadow; Steven R Leuthner; Bree Andrews; Joanne Lagatta; Arend Bos; Laura Lane; A A Eduard Verhagen
Journal:  J Pediatr       Date:  2011-02-26       Impact factor: 4.406

6.  Medical end-of-life decisions made for neonates and infants in the Netherlands.

Authors:  A van der Heide; P J van der Maas; G van der Wal; C L de Graaff; J G Kester; L A Kollée; R de Leeuw; R A Holl
Journal:  Lancet       Date:  1997-07-26       Impact factor: 79.321

7.  Dutch experience of monitoring active ending of life for newborns.

Authors:  Hilde M Buiting; Maartje A C Karelse; Hens A A Brouwers; Bregje D Onwuteaka-Philipsen; Agnes van der Heide; Johannes J M van Delden
Journal:  J Med Ethics       Date:  2010-04       Impact factor: 2.903

8.  Neuromuscular blockers--a means of palliation?

Authors:  L Hawryluck
Journal:  J Med Ethics       Date:  2002-06       Impact factor: 2.903

9.  [Deliberate termination of life in newborns in The Netherlands; review of all 22 reported cases between 1997 and 2004].

Authors:  A A E Verhagen; J J Sol; O F Brouwer; P J Sauer
Journal:  Ned Tijdschr Geneeskd       Date:  2005-01-22

Review 10.  Ethical reflections on end-of-life signs and symptoms in the intensive care setting: a place for neuromuscular blockers?

Authors:  Cédric Daubin; Lise Haddad; Dominique Folscheid; Alexandre Boyer; Ludivine Chalumeau-Lemoine; Olivier Guisset; Philippe Hubert; Jérôme Pillot; René Robert; Didier Dreyfuss
Journal:  Ann Intensive Care       Date:  2014-07-08       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.